An oral delivery vehicle based on konjac glucomannan acetate targeting the colon for inflammatory bowel disease therapy.

导出 LinkOut

翻译打印收藏纠错

作者： Chuang,Wang ^[1] ; Zhenzhao,Guo ^[2] ; Jialuo,Liang ^[3] ; Na,Li ^[1] ; Rijian,Song ^[1] ; Lei,Luo ^[2] ; Yilong,Ai ^[2] ; Xia,Li ^[1] ; Shunqing,Tang ^[1]

作者单位： Foshan Stomatology Hospital and School of Medicine, Foshan University, Foshan, China. ^[1] Biomedical Engineering Institute, Jinan University, Guangzhou, China. ^[2] Guangdong Engineering Research Center of Oral Restoration and Reconstruction, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China. ^[3]

关键词 colonic macrophages inflammatory bowel disease konjac glucomannan nanoparticle targeting delivery

DOI 10.3389/fbioe.2022.1025155

PMID 36440435

发布时间 2022-11-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in bioengineering and biotechnology

2022年10卷

1025155页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

An oral delivery vehicle based on konjac glucomannan acetate targeting the colon for inflammatory bowel disease therapy.

Frontiers in bioengineering and biotechnology

相似文献

Frontiers in bioengineering and biotechnology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

An oral delivery vehicle based on konjac glucomannan acetate targeting the colon for inflammatory bowel disease therapy.

Frontiers in bioengineering and biotechnology

相似文献

Frontiers in bioengineering and biotechnology

相关期刊

检索历史清除